• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 995
Device Problem Insufficient Information (3190)
Patient Problems Endocarditis (1834); Hemorrhage/Bleeding (1888); Rupture (2208); Fibrosis (3167); Pericardial Effusion (3271); Pulmonary Valve Insufficiency/ Regurgitation (4452)
Event Date 09/11/2012
Event Type  Injury  
Manufacturer Narrative
Citation: weimar t et al.Strategies for biological heart valve replacement: stentless xenografts fail to evolve into an alternative pulmonary valve substitute in a ross procedure.Biotechnol j.2013 mar;8(3):345-51.Doi: 10.1002/biot.201200288.Article online 11 sep 2012.Earliest date of publish used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information from a literature article regarding the early and mid-term outcomes of stentless bioprostheses in comparison to pulmonary homografts as the pulmonary valve substitute in the ross procedure.All data was retrospectively collected from a single center between 2004 and 2008.The overall study population included 139 patients and was divided into two groups: homograft group (106 patients) and stentless group (33 patients).In the stentless group, all patients underwent right ventricular outflow tract reconstruction with medtronic freestyle bioprosthetic valves (predominantly male, median age 43 years).No serial numbers were provided.Among all 139 patients, the overall mortality at one-year follow-up was 1.4% (2 patients).The causes of death included: cardiac arrest that occurred nine days after discharge and medication-induced bradycardia was suspected (1), and non-cardiovascular causes (1).The type of product (pulmonary homograft or stentless freestyle valve) implanted in these two patients was not reported.Based on the available information, medtronic product was not directly associated with the deaths.Among all 139 patients, adverse events included: reoperation due to double-valve endocarditis (implant duration unknown).Based on the available information, medtronic product may have been associated with the adverse event.Among all patients in the stentless group, adverse events included: reoperation for bleeding or pericardial effusion; valve explanted and replaced within two years post-implant due to fibrous tissue ingrowth at the proximal anastomosis causing elevated gradients (more than 30 mmhg); and mild to severe pulmonary insufficiency.In addition, it was mentioned that 14 freestyle valves from a separate study were explanted due to non-infective aortic wall rupture.Based on the available information, medtronic product was associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE AORTIC ROOT BIOPROSTHESIS
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key11121414
MDR Text Key226768934
Report Number2025587-2021-00035
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P970031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 01/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/05/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number995
Device Catalogue Number995
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/11/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age43 YR
-
-